These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 33434260)

  • 1. The design of cyclometalated iridium(iii)-metformin complexes for hypoxic cancer treatment.
    Yang J; Fang HJ; Cao Q; Mao ZW
    Chem Commun (Camb); 2021 Jan; 57(9):1093-1096. PubMed ID: 33434260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorescence monitoring of hypoxic microenvironment in solid-tumors to evaluate chemotherapeutic effects using the hypoxia-sensitive iridium (III) coordination compound.
    Zeng Y; Liu Y; Shang J; Ma J; Wang R; Deng L; Guo Y; Zhong F; Bai M; Zhang S; Wu D
    PLoS One; 2015; 10(3):e0121293. PubMed ID: 25786221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
    Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
    J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization and biological evaluation of two cyclometalated iridium(III) complexes containing a glutathione S-transferase inhibitor.
    Zhao J; Gao Y; He W; Wang W; Hu W; Sun Y
    J Inorg Biochem; 2023 Jan; 238():112050. PubMed ID: 36332411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
    Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
    Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ
    ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
    Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW
    Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
    Laws K; Eskandari A; Lu C; Suntharalingam K
    Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Ir
    Wu XW; Zheng Y; Wang FX; Cao JJ; Zhang H; Zhang DY; Tan CP; Ji LN; Mao ZW
    Chemistry; 2019 May; 25(28):7012-7022. PubMed ID: 30913329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iridium(iii) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.
    He L; Xiong K; Wang L; Guan R; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2021 Aug; 57(67):8308-8311. PubMed ID: 34319315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
    Ouyang M; Zeng L; Huang H; Jin C; Liu J; Chen Y; Ji L; Chao H
    Dalton Trans; 2017 May; 46(20):6734-6744. PubMed ID: 28488721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Organometallic Tetraphenylethylene⋅Iridium(III) Complexes with Antineoplastic Activity.
    Liu X; He X; Zhang X; Wang Y; Liu J; Hao X; Zhang Y; Yuan XA; Tian L; Liu Z
    Chembiochem; 2019 Nov; 20(21):2767-2776. PubMed ID: 31119850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.
    Novohradsky V; Liu Z; Vojtiskova M; Sadler PJ; Brabec V; Kasparkova J
    Metallomics; 2014 Mar; 6(3):682-90. PubMed ID: 24448555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir
    Novohradsky V; Rovira A; Hally C; Galindo A; Vigueras G; Gandioso A; Svitelova M; Bresolí-Obach R; Kostrhunova H; Markova L; Kasparkova J; Nonell S; Ruiz J; Brabec V; Marchán V
    Angew Chem Int Ed Engl; 2019 May; 58(19):6311-6315. PubMed ID: 30889300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared phosphorescent cyclometalated platinum (II) and iridium (III) complexes with metformin moiety: Design and study towards anticancer theranostic agents.
    Yang J; Wang WT; Shi ZD; Yang R; Liao XL; Yang B; Gao CZ
    J Inorg Biochem; 2022 Dec; 237():111992. PubMed ID: 36126432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
    Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity.
    Lu L; Liu LJ; Chao WC; Zhong HJ; Wang M; Chen XP; Lu JJ; Li RN; Ma DL; Leung CH
    Sci Rep; 2015 Sep; 5():14544. PubMed ID: 26416333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusting the lipid-water distribution coefficient of iridium(III) complexes to enhance the cellular penetration and treatment efficacy to antagonize cisplatin resistance in cervical cancer.
    Huang W; Chen Z; Hou L; Feng P; Li Y; Chen T
    Dalton Trans; 2020 Aug; 49(33):11556-11564. PubMed ID: 32716436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.